Heart Disease News and Research

Latest Heart Disease News and Research

Major trial finds apixaban reduces stroke risk in patients with device-detected atrial fibrillation

The widely available blood thinner apixaban substantially reduced stroke in at-risk patients with a type of atrial fibrillation only detectable by a pacemaker or other implanted cardiac electronic device, a global study has found.

13 Nov 2023

Intensive blood pressure control reduces dementia risk in adults with hypertension

An intensive, four-year blood-pressure intervention significantly reduced the risk of developing dementia among adults with high blood pressure compared to people who received usual care, in a study reported as late-breaking science today at the American Heart Association's Scientific Sessions 2023.

13 Nov 2023

Current vitamin D dosing recommendations not high enough for optimal heart health, studies suggest

Low levels of Vitamin D have been shown to be associated with a higher risk of having a cardiac event, like a heart attack or stroke.

13 Nov 2023

Recaticimab injection every 1-3 months may safely lower bad cholesterol

A new PCSK9 inhibitor (recaticimab) injected every one to three months may work safely and provide more flexible dosing to lower cholesterol, according to late-breaking science presented today at the American Heart Association's Scientific Sessions 2023.

13 Nov 2023

Abelacimab significantly reduces bleeding risk in atrial fibrillation patients with stroke risk

An experimental anti-clotting medication, abelacimab, significantly reduced bleeding among people with atrial fibrillation (or AFib) who were at risk of stroke, according to results of the AZALEA-TIMI 71 trial, presented today as late-breaking science at the American Heart Association's Scientific Sessions 2023.

13 Nov 2023

Study shows long-term cardiovascular benefits of tight blood pressure control after pregnancy

Women with high blood pressure during pregnancy had long-term blood pressure and cardiac benefits if their blood pressure was carefully controlled for the first few weeks after having a baby, according to late-breaking science presented today at the American Heart Association's Scientific Sessions 2023.

13 Nov 2023

New drug zilebesiran effectively lowers blood pressure for six months, study finds

A single injection of the experimental medication zilebesiran was safe and effective in reducing systolic blood pressure in people with mild-to-moderate high blood pressure for up to six months, as detailed in the Phase 2 of the KARDIA study, reported as late-breaking science today at the American Heart Association's Scientific Sessions 2023.

13 Nov 2023

Researchers encourage flexible approach to blood transfusion decisions for heart attack patients with anemia

A National Institutes of Health-supported study found that the type of transfusion approach used to support adults who developed anemia after a heart attack did not make a significant difference in their likelihood of having another heart attack or dying within 30 days.

13 Nov 2023

Single injection of new medication effectively eliminates Lp(a) for nearly one year

In the first human trial of a new therapeutic, a single injection of lepodisiran reduced levels of lipoprotein(a), or Lp(a), to undetectable levels for nearly one year, according to late-breaking science presented today at the American Heart Association's Scientific Sessions 2023.

13 Nov 2023

CRISPR-based gene-editing therapy could offer hope for people with inherited high LDL cholesterol

A single infusion of a CRISPR-based gene-editing therapy significantly reduced low-density lipoprotein cholesterol (LDL, the "bad cholesterol") in people who carry one gene for the inherited condition that results in very high LDL cholesterol levels and a high risk of heart attack at an early age, according to late-breaking science presented today at the American Heart Association's Scientific Sessions 2023.

13 Nov 2023

SELECT trial: Semaglutide reduces cardiovascular events by 20% in overweight or obese patients without diabetes

Findings from a multi-center, international clinical trial reported by a Cleveland Clinic physician show that semaglutide reduced cardiovascular events by 20% in adults with overweight or obesity and established cardiovascular disease who do not have diabetes.

13 Nov 2023

Is there an association between atrial fibrillation onset age and incident dementia?

Whether younger age at atrial fibrillation (AF) diagnosis is associated with a higher risk of incident dementia.

13 Nov 2023

Food allergies may be linked to increased cardiovascular death risk, study finds

Sensitivity to common food allergens such as dairy and peanuts could be an important and previously unappreciated cause of heart disease, new research suggests – and the increased risk for cardiovascular death includes people without obvious food allergies.

13 Nov 2023

Liberal blood transfusion may reduce recurrence risk, improve survival in heart attack patients with anemia

An international clinical trial led by physician Jeffrey L. Carson, distinguished professor of medicine at Rutgers Robert Wood Johnson Medical School, found that a liberal blood transfusion given to patients who have had a heart attack and have anemia may reduce the risk of a reoccurrence and improve survival rates.

12 Nov 2023

Australian study shows combined genomic screening for major hereditary diseases is cost-effective and health-saving

In an Australian study published in EClinicalMedicine, researchers evaluated the impact of a combined genomic screening program for hereditary breast and ovarian cancer, Lynch syndrome, and familial hypercholesterolemia in young adults. The program proved to be cost-effective, reducing healthcare costs and averting numerous health events, while emphasizing the need for further optimization and equitable access within public healthcare systems.

12 Nov 2023

Heart attack patients without traditional risk factors have high levels of coronary calcium, study finds

While high cholesterol, high blood pressure, diabetes and smoking are well known heart disease risks, not everyone who has a heart attack has them.

11 Nov 2023

Lowering sodium intake can help reduce blood pressure

Nearly everyone can lower their blood pressure, even people currently on blood pressure-reducing drugs, by lowering their sodium intake, reports a new study from Northwestern Medicine, Vanderbilt University Medical Center and the University of Alabama at Birmingham.

11 Nov 2023

Study identifies link between sleep apnea and development of atrial fibrillation

New research from Cleveland Clinic has identified a link between sleep apnea and the development of atrial fibrillation, a common heart rhythm disorder.

10 Nov 2023

Autologous stem cell transplant shows promise for young patients with severe juvenile systemic sclerosis

New research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, shows that patients with refractory juvenile systemic sclerosis improved significantly on nearly all measures for two years following autologous stem cell transplant.

10 Nov 2023

One in six patients with coronary artery disease found to have non-ischemic or dual cardiomyopathy

Researchers from the University of Minnesota Medical School examining the cause of cardiomyopathy discovered one out of every six patients with coronary artery disease had non-ischemic or dual cardiomyopathy.

10 Nov 2023

Previous
1
...
4
5
6
7
8
9
10
...
2765
Next

Heart Disease News and Research

Latest Heart Disease News and Research

Major trial finds apixaban reduces stroke risk in patients with device-detected atrial fibrillation

Intensive blood pressure control reduces dementia risk in adults with hypertension

Current vitamin D dosing recommendations not high enough for optimal heart health, studies suggest

Recaticimab injection every 1-3 months may safely lower bad cholesterol

Abelacimab significantly reduces bleeding risk in atrial fibrillation patients with stroke risk

Study shows long-term cardiovascular benefits of tight blood pressure control after pregnancy

New drug zilebesiran effectively lowers blood pressure for six months, study finds

Researchers encourage flexible approach to blood transfusion decisions for heart attack patients with anemia

Single injection of new medication effectively eliminates Lp(a) for nearly one year

CRISPR-based gene-editing therapy could offer hope for people with inherited high LDL cholesterol

SELECT trial: Semaglutide reduces cardiovascular events by 20% in overweight or obese patients without diabetes

Is there an association between atrial fibrillation onset age and incident dementia?

Food allergies may be linked to increased cardiovascular death risk, study finds

Liberal blood transfusion may reduce recurrence risk, improve survival in heart attack patients with anemia

Australian study shows combined genomic screening for major hereditary diseases is cost-effective and health-saving

Heart attack patients without traditional risk factors have high levels of coronary calcium, study finds

Lowering sodium intake can help reduce blood pressure

Study identifies link between sleep apnea and development of atrial fibrillation

Autologous stem cell transplant shows promise for young patients with severe juvenile systemic sclerosis

One in six patients with coronary artery disease found to have non-ischemic or dual cardiomyopathy

Arxspan BioDrive: A Versatile Solution for Molecular Biology

One Health, One Mission: The World Organisation for Animal Health on the AMR Frontline

Uniting Against Resistance: The World Health Organization for World Antimicrobial Awareness Week 2023

Heart Disease News and Research

Latest Heart Disease News and Research

Arxspan BioDrive: A Versatile Solution for Molecular Biology

One Health, One Mission: The World Organisation for Animal Health on the AMR Frontline

Uniting Against Resistance: The World Health Organization for World Antimicrobial Awareness Week 2023

Newsletters you may be interested in